Omnicell (OMCL) Asset Writedowns and Impairment (2010 - 2024)
Omnicell's (OMCL) quarterly Asset Writedowns and Impairment came in at $5.4 million in Q2 2024, up 147.14% quarter-over-quarter from $2.2 million in Q4 2023.
Powered by 
Analysis
Omnicell (OMCL) Asset Writedowns and Impairment (2010 - 2024) Analysis & Trends
Omnicell (OMCL) has reported Asset Writedowns and Impairment for 10 consecutive years, with $5.4 million the latest figure, recorded in Q2 2024.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $5.4 million in Q2 2024; TTM through Sep 2025 was $5.4 million, a 28.81% decrease from a year earlier, with the FY2024 full-year figure at $5.4 million, down 46.0% from the prior year.
- Asset Writedowns and Impairment was $5.4 million for Q2 2024 at Omnicell, up from $2.2 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $7.8 million in Q1 2023 and troughed at $300000.0 in Q3 2022.
- A 3-year average of $3.5 million and a median of $3.3 million in 2022 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 334.17% in 2023, down 45.13% in 2023.
- Over 3 years, Asset Writedowns and Impairment stood at $4.0 million in 2022, then slumped by 45.13% to $2.2 million in 2023, then soared by 147.14% to $5.4 million in 2024.
- The last three Asset Writedowns and Impairment figures came in at $5.4 million (Q2 2024), $2.2 million (Q4 2023), and $7.8 million (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 5.40 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Mar 31, 2023 | 7.82 Mn |
| Dec 31, 2022 | 3.98 Mn |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Jun 30, 2016 | 602,000.00 |
| Mar 31, 2016 | 248,000.00 |
| Dec 31, 2015 | -542,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Jun 30, 2015 | 199,000.00 |
| Mar 31, 2015 | 281,000.00 |
| Dec 31, 2014 | -500,000.00 |
| Sep 30, 2014 | 414,000.00 |
| Jun 30, 2014 | 219,000.00 |
| Mar 31, 2014 | 217,000.00 |
| Mar 31, 2013 | 1.76 Mn |
| Dec 31, 2012 | 73,000.00 |
| Sep 30, 2012 | 174,000.00 |